These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


351 related items for PubMed ID: 17872467

  • 1. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
    Cerrone M, Noujaim SF, Tolkacheva EG, Talkachou A, O'Connell R, Berenfeld O, Anumonwo J, Pandit SV, Vikstrom K, Napolitano C, Priori SG, Jalife J.
    Circ Res; 2007 Nov 09; 101(10):1039-48. PubMed ID: 17872467
    [Abstract] [Full Text] [Related]

  • 2. Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
    Neco P, Torrente AG, Mesirca P, Zorio E, Liu N, Priori SG, Napolitano C, Richard S, Benitah JP, Mangoni ME, Gómez AM.
    Circulation; 2012 Jul 24; 126(4):392-401. PubMed ID: 22711277
    [Abstract] [Full Text] [Related]

  • 3. Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia.
    Herron TJ, Milstein ML, Anumonwo J, Priori SG, Jalife J.
    Heart Rhythm; 2010 Aug 24; 7(8):1122-8. PubMed ID: 20538074
    [Abstract] [Full Text] [Related]

  • 4. Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model.
    Liu N, Colombi B, Memmi M, Zissimopoulos S, Rizzi N, Negri S, Imbriani M, Napolitano C, Lai FA, Priori SG.
    Circ Res; 2006 Aug 04; 99(3):292-8. PubMed ID: 16825580
    [Abstract] [Full Text] [Related]

  • 5. In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.
    Chen B, Guo A, Gao Z, Wei S, Xie YP, Chen SR, Anderson ME, Song LS.
    Circ Arrhythm Electrophysiol; 2012 Aug 01; 5(4):841-9. PubMed ID: 22722659
    [Abstract] [Full Text] [Related]

  • 6. Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.
    Bai Y, Jones PP, Guo J, Zhong X, Clark RB, Zhou Q, Wang R, Vallmitjana A, Benitez R, Hove-Madsen L, Semeniuk L, Guo A, Song LS, Duff HJ, Chen SR.
    Circ Res; 2013 Aug 16; 113(5):517-26. PubMed ID: 23856523
    [Abstract] [Full Text] [Related]

  • 7. Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor.
    Cerrone M, Colombi B, Santoro M, di Barletta MR, Scelsi M, Villani L, Napolitano C, Priori SG.
    Circ Res; 2005 May 27; 96(10):e77-82. PubMed ID: 15890976
    [Abstract] [Full Text] [Related]

  • 8. Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
    Fernández-Velasco M, Rueda A, Rizzi N, Benitah JP, Colombi B, Napolitano C, Priori SG, Richard S, Gómez AM.
    Circ Res; 2009 Jan 30; 104(2):201-9, 12p following 209. PubMed ID: 19096022
    [Abstract] [Full Text] [Related]

  • 9. Purkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapy.
    Kang G, Giovannone SF, Liu N, Liu FY, Zhang J, Priori SG, Fishman GI.
    Circ Res; 2010 Aug 20; 107(4):512-9. PubMed ID: 20595652
    [Abstract] [Full Text] [Related]

  • 10. Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia.
    Nam GB, Burashnikov A, Antzelevitch C.
    Circulation; 2005 May 31; 111(21):2727-33. PubMed ID: 15911700
    [Abstract] [Full Text] [Related]

  • 11. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
    Sedej S, Heinzel FR, Walther S, Dybkova N, Wakula P, Groborz J, Gronau P, Maier LS, Vos MA, Lai FA, Napolitano C, Priori SG, Kockskämper J, Pieske B.
    Cardiovasc Res; 2010 Jul 01; 87(1):50-9. PubMed ID: 20080988
    [Abstract] [Full Text] [Related]

  • 12. Targeting intracellular calcium cycling in catecholaminergic polymorphic ventricular tachycardia: a theoretical investigation.
    Sung RJ, Lo CP, Hsiao PY, Tien HC.
    Am J Physiol Heart Circ Physiol; 2011 Oct 01; 301(4):H1625-38. PubMed ID: 21742998
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.
    Liu N, Ruan Y, Denegri M, Bachetti T, Li Y, Colombi B, Napolitano C, Coetzee WA, Priori SG.
    J Mol Cell Cardiol; 2011 Jan 01; 50(1):214-22. PubMed ID: 20937285
    [Abstract] [Full Text] [Related]

  • 15. [Ventricular arrhythmias of catecholaminergic origin and sudden death].
    Jalife J.
    Arch Cardiol Mex; 2007 Jan 01; 77 Suppl 4():S4-175-7. PubMed ID: 18938722
    [Abstract] [Full Text] [Related]

  • 16. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia.
    Marks AR, Priori S, Memmi M, Kontula K, Laitinen PJ.
    J Cell Physiol; 2002 Jan 01; 190(1):1-6. PubMed ID: 11807805
    [Abstract] [Full Text] [Related]

  • 17. Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death.
    Jiang D, Xiao B, Zhang L, Chen SR.
    Circ Res; 2002 Aug 09; 91(3):218-25. PubMed ID: 12169647
    [Abstract] [Full Text] [Related]

  • 18. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
    Shan J, Xie W, Betzenhauser M, Reiken S, Chen BX, Wronska A, Marks AR.
    Circ Res; 2012 Aug 31; 111(6):708-17. PubMed ID: 22828895
    [Abstract] [Full Text] [Related]

  • 19. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy.
    Kannankeril PJ, Mitchell BM, Goonasekera SA, Chelu MG, Zhang W, Sood S, Kearney DL, Danila CI, De Biasi M, Wehrens XH, Pautler RG, Roden DM, Taffet GE, Dirksen RT, Anderson ME, Hamilton SL.
    Proc Natl Acad Sci U S A; 2006 Aug 08; 103(32):12179-84. PubMed ID: 16873551
    [Abstract] [Full Text] [Related]

  • 20. Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves.
    Paavola J, Viitasalo M, Laitinen-Forsblom PJ, Pasternack M, Swan H, Tikkanen I, Toivonen L, Kontula K, Laine M.
    Eur Heart J; 2007 May 08; 28(9):1135-42. PubMed ID: 17347175
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.